-
1
-
-
70349469696
-
Antiangiogenic approaches to age-related macular degeneration today
-
Bressler NM. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 2009;116:S15-S23.
-
(2009)
Ophthalmology
, vol.116
-
-
Bressler, N.M.1
-
2
-
-
65549162660
-
Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration
-
Ciulla TA, Rosenfeld PJ. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration. Curr Opin Ophthalmol 2009;20:158-165.
-
(2009)
Curr Opin Ophthalmol
, vol.20
, pp. 158-165
-
-
Ciulla, T.A.1
Rosenfeld, P.J.2
-
3
-
-
33750296920
-
The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
-
Fung AE, Rosenfeld PJ, Reichel E. The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide. Br J Ophthalmol 2006;90:1344-1349.
-
(2006)
Br J Ophthalmol
, vol.90
, pp. 1344-1349
-
-
Fung, A.E.1
Rosenfeld, P.J.2
Reichel, E.3
-
4
-
-
67649884473
-
Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration
-
Landa G, Amde W, Doshi V, et al. Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration. Ophthalmologica 2009;223:370-375.
-
(2009)
Ophthalmologica
, vol.223
, pp. 370-375
-
-
Landa, G.1
Amde, W.2
Doshi, V.3
-
6
-
-
67149143227
-
Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections
-
KahookMY, Kimura AE,Wong LJ, Ammar DA, Maycotte MA, Mandava N. Sustained elevation in intraocular pressure associated with intravitreal bevacizumab injections. Ophthalmic Surg Lasers Imaging 2009;40:293-295.
-
(2009)
Ophthalmic Surg Lasers Imaging
, vol.40
, pp. 293-295
-
-
Kahook, M.Y.1
Kimura, A.E.2
Wong, L.J.3
Ammar, D.A.4
Maycotte, M.A.5
Mandava, N.6
-
7
-
-
77953360250
-
Avastin and Risk of Glaucoma
-
September 30-October 4, . New York, NY. Abstract
-
Carver J, Bouska C, Corey R. Avastin and Risk of Glaucoma. Retina Congress 2009 New York, September 30-October 4, 2009. New York, NY. Abstract.
-
(2009)
Retina Congress 2009 New York
-
-
Carver, J.1
Bouska, C.2
Corey, R.3
-
8
-
-
37749036215
-
Intravitreal bevacizumab (Avastin) causing acute glaucoma: An unreported complication
-
Jalil A, Fenerty C, Charles S. Intravitreal bevacizumab (Avastin) causing acute glaucoma: an unreported complication. Eye 2007;21:1541.
-
(2007)
Eye
, vol.21
, pp. 1541
-
-
Jalil, A.1
Fenerty, C.2
Charles, S.3
-
9
-
-
0026516665
-
Unexpected interaction of some anti-TNP hybridoma antibodies with Superose HPLC gel filtration resins
-
Michaelsen TE, Lofsgaard MF, Aase A, Heyman B. Unexpected interaction of some anti-TNP hybridoma antibodies with Superose HPLC gel filtration resins. J Immunol Methods 1992;146:9-16.
-
(1992)
J Immunol Methods
, vol.146
, pp. 9-16
-
-
Michaelsen, T.E.1
Lofsgaard, M.F.2
Aase, A.3
Heyman, B.4
-
10
-
-
33645641520
-
Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I/II multicenter, controlled, multidose study
-
Heier JS, Antoszyk AN, Pavan PR, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: a phase I/II multicenter, controlled, multidose study. Ophthalmology 2006;113:633.el-e4.
-
(2006)
Ophthalmology
, vol.113
-
-
Heier, J.S.1
Antoszyk, A.N.2
Pavan, P.R.3
-
11
-
-
33745771388
-
Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing
-
Bakri SJ, Snyder MR, Pulido JS, McCannel CA, Weiss WT, Singh RJ. Six-month stability of bevacizumab (Avastin) binding to vascular endothelial growth factor after withdrawal into a syringe and refrigeration or freezing. Retina 2006;26: 519-522.
-
(2006)
Retina
, vol.26
, pp. 519-522
-
-
Bakri, S.J.1
Snyder, M.R.2
Pulido, J.S.3
McCannel, C.A.4
Weiss, W.T.5
Singh, R.J.6
-
12
-
-
0141567459
-
Physical stability of proteins in aqueous solution: Mechanism and driving forces in nonnative protein aggregation
-
Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm Res 2003;20:1325-1336.
-
(2003)
Pharm Res
, vol.20
, pp. 1325-1336
-
-
Chi, E.Y.1
Krishnan, S.2
Randolph, T.W.3
Carpenter, J.F.4
-
13
-
-
68949085124
-
Protein aggregation: Pathways, induction factors and analysis
-
Mahler HC, Friess W, Grauschopf U, Kiese S. Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 2009;98:2909-2934.
-
(2009)
J Pharm Sci
, vol.98
, pp. 2909-2934
-
-
Mahler, H.C.1
Friess, W.2
Grauschopf, U.3
Kiese, S.4
-
14
-
-
52449090177
-
Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: Structure and degradation pathways
-
Kerwin BA. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci 2008;97:2924-2935.
-
(2008)
J Pharm Sci
, vol.97
, pp. 2924-2935
-
-
Kerwin, B.A.1
-
16
-
-
68949136656
-
Silicone oil- and agitationinduced aggregation of a monoclonal antibody in aqueous solution
-
Thirumangalathu R, Krishnan S, Ricci MS, Brems DN, Randolph TW, Carpenter JF. Silicone oil- and agitationinduced aggregation of a monoclonal antibody in aqueous solution. J Pharm Sci 2009;98:3167-3181.
-
(2009)
J Pharm Sci
, vol.98
, pp. 3167-3181
-
-
Thirumangalathu, R.1
Krishnan, S.2
Ricci, M.S.3
Brems, D.N.4
Randolph, T.W.5
Carpenter, J.F.6
-
17
-
-
68949119488
-
Monoclonal antibody inter actions with micro- and nanoparticles: Adsorption, aggregation and accelerated stress studies
-
Bee JS, Chui D, Sawicki S, et al. Monoclonal antibody inter actions with micro- and nanoparticles: adsorption, aggregation and accelerated stress studies. J Pharm Sci 2009;98:3218-3238.
-
(2009)
J Pharm Sci
, vol.98
, pp. 3218-3238
-
-
Bee, J.S.1
Chui, D.2
Sawicki, S.3
-
19
-
-
70349263362
-
Evaluation of the immunostimulatory potential of stopper extractables and leachables by using dendritic cells as readout
-
Mueller R, Karle A, Vogt A, et al. Evaluation of the immunostimulatory potential of stopper extractables and leachables by using dendritic cells as readout. J Pharm Sci 2009;98:3548-3561.
-
(2009)
J Pharm Sci
, vol.98
, pp. 3548-3561
-
-
Mueller, R.1
Karle, A.2
Vogt, A.3
-
20
-
-
64849085452
-
Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin)
-
GeorgopoulosM, Polak K, Prager F, Prunte C, Schmidt-Erfurth U. Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). Br J Ophthalmol 2009;93:457-462.
-
(2009)
Br J Ophthalmol
, vol.93
, pp. 457-462
-
-
Georgopoulos, M.1
Polak, K.2
Prager, F.3
Prunte, C.4
Schmidt-Erfurth, U.5
-
21
-
-
0015467326
-
Chronic open-angle glaucoma secondary to rhegmatogenous retinal detachment
-
Schwartz A. Chronic open-angle glaucoma secondary to rhegmatogenous retinal detachment. Trans Am Ophthalmol Soc 1972;70:178-189.
-
(1972)
Trans Am Ophthalmol Soc
, vol.70
, pp. 178-189
-
-
Schwartz, A.1
-
22
-
-
0035888982
-
Experimental glaucoma in the primate induced by latex microspheres
-
Weber AJ, Zelenak D. Experimental glaucoma in the primate induced by latex microspheres. J Neurosci Methods 2001;111: 39-48.
-
(2001)
J Neurosci Methods
, vol.111
, pp. 39-48
-
-
Weber, A.J.1
Zelenak, D.2
|